News

Update May 2020

Read our analysis of the latest developments at EU level and a report of recent BioMed Alliance activities in the new Update May.

BioMed Alliance launches new page with COVID-19 related resources

Details

25 May 2020

The BioMed Alliance launched a new page providing an overview of resources on COVID-19. The page contains information on BioMed Alliance activities and provides and highlights materials that medical & research societies have published on the COVID-19 virus.

New article in UEG Journal: ‘Joining forces to strengthen European health research’

Details

25 May 2020

BioMed Alliance Board Member Berthold Koletzo, Loredana Simulescu (BioMed Alliance) and Mathilde Ollivier (UEG) have published an article in the United European Gastroenterology Journal explaining how joining forces is essential to strengthen European health research. They highlight the successes of cross-border health research and European funding programmes, explain how Horizon Europe is structured, stress the need for adequate funding and outline the activities of the BioMed Alliance.

Update April 2020

Our Update April is available now and includes a comprehensive overview of the latest news around the BioMed Alliance and relevant developments at EU level.

Report BioMed Alliance-FEAM workshop on the future of health research

Details

20 April 2020

On 31 January, the BioMed Alliance organised a joint workshop with the Federation of European Academies of Medicine (FEAM) on the Future of European Health Research. The workshop took place in the European Parliament and both European policy makers and researchers held a series of interesting presentations on health research.

BioMed Alliance releases statement on delay MDR application date

Details

08 April 2020

The BioMed Alliance published a statement on 9 April welcoming the European Commission’s proposal to postpone the application date of the Medical Devices regulation by one year, to 26 May 2021. The statement highlights several key elements that should be taken into account if the postponement will be approved.

Update March 2020

Read our new March Update to get an overview of our activities and news, particularly related to the COVID-19 Pandemic.

BioMed Alliance calls for support for Medical Societies during COVID-19 pandemic

Details

30 March 2020

The BioMed Alliance released a new statement and a letter to Commission President Ursula von der Leyen calling for support for medical and research societies to ensure continued guidance for healthcare professionals during the COVID-19 Pandemic.

The COVID-19 pandemic poses a major challenge that has a disruptive effect on European health systems and societies. European health professionals are working around the clock to save the lives of European patients, and governments and the EU Institutions are doing everything in their power to support their heroic efforts. However, the medical and research societies that health professionals rely on for up-to-date information on clinical practice are facing serious challenges. As medical congresses are being cancelled or postponed, not-for-profit societies are faced with substantial costs that may threaten their existence and thus their ability to provide clinical guidance to health professionals. Therefore, the Biomedical Alliance in Europe calls on the EU and Member States to support medical societies to ensure they can continue providing their services now and in the future.

Read the letter to President Ursula von der Leyen here and the statement here

Update February 2020

Details

02 March 2020

Take a look at our February Update to find more information about our activities in this month.

High level EU Health Summit will take place on 4 & 5 May 2020 in the Flemish Parliament

Details

27 February 2020

The EU Health Coalition, in which the BioMed Alliance is an active member and chairs the research & innovation policy group, announced that the next EU Health Summit takes place on 4-5 May 2020. The high-level summit will be held in the Flemish Parliament and we look forward to organising the programme together with our partners. The conference will focus on the implementation of an updated version of the recommendations that were presented during the last conference in the end of 2018.

EFLM becomes the 33rd member of the BioMed Alliance

Details

19 February 2020

The European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) has now officially joined the BioMed Alliance. It is the 33rd organisation to join the BioMed Alliance, bringing important expertise related to the fields of clinical chemistry and laboratory medicine. We would like to warmly welcome them to our growing organisation.

EFLM connects National Societies of Clinical Chemistry and Laboratory Medicine and creates a platform for all European “Specialists in Laboratory Medicine”. EFLM provides European leadership in Clinical Chemistry and Laboratory Medicine to national professional societies, the diagnostic industry and to governmental and non-governmental organisations in order to serve the public interest in health care. EFLM represents the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) in Europe.

Update January 2020

Details

03 February 2020

Read the first Update of the new decade here to see how we started the year and to get a glimpse of what lies ahead.

New year, new leadership

Details

15 January 2020

The BioMed Alliance started 2020 well, with a new President, President-Elect and a new Board Member. We look forward to working with them on the many interesting activities that we are planning this year.

In January, we welcomed our new President, Prof. Wilfried Ellmeier from the Medical University of Vienna. He has prepared for this role over the past two years as President-Elect and has extensive experience within the BioMed Alliance.

This means that Prof. Axel Pries has stepped down as president and will continue to be active as Past-President. We can all agree that Prof. Pries has been a great president that was very committed to the BioMed Alliance. Under his leadership, the organisation has developed substantially.

Prof.Gunhild Waldemar was appointed as President-Elect, her candidacy was approved during the General Assembly last November. Prof. Tobias Welte has taken over her role as treasurer.

We will also welcome a new Board Member, Prof. Tom Hemming Karlsen took over the seat of Prof. Colm O’Morain, who has come to the end of his term in the Board and has played an important role in the BioMed Alliance as Board Member, President-Elect, President and Past-President.

BioMed Alliance organises joint EP event with FEAM on the future of European health research

Details

08 January 2020

The BioMed Alliance and FEAM joined forces to co-organise a workshop exploring opportunities and challenges for maximising the impact of health research in the coming years. The event: ‘Working together for the Future of European Health Research’ takes place on 31 January from 11.00-13.00 in the European Parliament. The two-hour workshop includes presentations from leading academics, stakeholder representatives, MEPs, and key policy makers in the European Commission. The event is hosted by MEP Cristian Bușoi (EPP), MEP Graça Carvalho (EPP) and MEP Petra De Sutter (Greens/EFA).

With the increasing disease burden and challenges faced by European healthcare systems, health research is more important than ever. It has a transformative impact on the lives of patients and provides return on investment to society. Nonetheless, bottlenecks persist, including fragmentations in the health research funding system and limitations to the sustainability of funding. Health research is constantly evolving, and policy makers and researchers should work together to ensure that researchers have access to new developments, concepts and technologies needed to develop innovative ideas. At the same time, efforts should focus on effectively scaling-up and implementing these innovations, so they quickly reach patients. Cross-sectoral and cross-border cooperation are key in ensuring health research meets societal needs. Therefore, FEAM and the BioMed Alliance partner with influential policy makers and experienced researchers to have an open discussion on the future of European health research.

For more information, the agenda is available here and the registration form can be found here.

Update December 2019

Details

19 December 2019

To mark the end of 2019, we would like to share a festive end-of-the-year Update with you. In this December edition you can find a brief summary of our activities in 2019, editorials written by our Board of Directors members and a preview of what lies ahead in 2020.

General Assembly elects Tom Hemming Karlsen to Board of Directors

Details

02 December 2019

During the BioMed Alliance General Assembly on 20 November several governance changes were discussed. Tom Hemming Karlsen from EASL was elected to the BioMed Alliance Board of Directors to replace Colm O’Morain, who has come to the end of his term in the Board. The Assembly also approved the nomination of Gunhild Waldemar as the next President-Elect.

Prof. Karlsen received the most votes out of the total of 6 candidates that applied for the vacant position. His experience as secretary general for EASL has provided him with expertise in EU Affairs and helped him get familiar with BioMed Alliance activities. We look forward to working with him in the coming years to continue expanding the BioMed Alliance.

Update November 2019

Details

02 December 2019

The November update provides an overview of a busy month for the BioMed Alliance and at EU level, take a look for more information.

Update October 2019

Details

04 November 2019

Read up on the latest developments related to the BioMed Alliance and EU Affairs in our new October Update

BioMed Alliance sets up IVD Working Group

Details

29 October 2019

The first meeting of the BioMed Alliance working group on In Vitro Diagnostics (IVD) is taking place on 12 November. This meeting will include experts from medical societies and experts from e.g. the European Commission and notified bodies. The meeting will focus on exchanging information on the new Regulation for In Vitro Diagnostics (IVDR) and on exploring how medical societies can support regulators in the implementation.

Interactions with the European Commission on the MDR implementation showed that there is an urgent need to set up a BioMed Alliance IVDR working group. The new regulation will significantly affect the evaluation and approval processes of in vitro diagnostics and medical professional input is essential for effective implementation. The first meeting will focus on the requirements of the IVDR and will define the future objectives and activities of the working group.

For more information, contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

ECCO joins the BioMed Alliance as a new member

Details

15 October 2019

The European CanCer Organisation (ECCO) has joined the BioMed Alliance as a new member bringing our membership to a total of 32 societies. We are happy that the ECCO Board and new CEO have made the decision to participate in our growing alliance and we are looking forward to working with them again on a number of common projects.

ECCO is a not-for-profit federation focussed on oncology that advocates for the right of all European cancer patients to high-quality treatment and care, promoting interaction between all organisations involved in cancer at European level. It is a multidisciplinary organisation that has 27 Member Societies representing over 150 000 professionals.